Navigation Links
Boston Scientific Completes Clinical Trial Enrollment for Third-Generation Drug-Eluting Stent
Date:10/8/2008

the TAXUS Element Stent System incorporates new balloon technology, intended to improve on Boston Scientific's market-leading Maverick(R) Balloon Catheter platform.

"The new alloy and stent design of TAXUS Element provides improved deliverability and visibility, even in patients with complex and challenging anatomy," said Dean J. Kereiakes, M.D., Medical Director at The Christ Hospital Heart and Vascular Center and The Lindner Research Center in Cincinnati and the principal investigator for the trials. "I am very enthusiastic about the potential the TAXUS Element Stent offers me to treat a broader range of patients."

The TAXUS PERSEUS clinical program will evaluate the efficacy and safety of the TAXUS Element Stent in two studies.

The first study, TAXUS PERSEUS Workhorse (A Prospective Evaluation in a Randomized Trial of the Safety and Efficacy of the Use of the TAXUS Element Paclitaxel-Eluting Coronary Stent System for the Treatment of De Novo Coronary Artery Lesions), will evaluate the safety and efficacy of the TAXUS Element Stent compared to Boston Scientific's first generation drug-eluting stent, the TAXUS(R) Express(TM) Stent. This 3:1 randomized study will evaluate 1,264 patients from 94 sites in the U.S., Australia, New Zealand and Singapore with "workhorse" lesions from 2.75 to 4.0 millimeters in diameter. The primary endpoint of the workhorse study is target lesion failure (TLF) at 12 months, and its secondary endpoint is in-segment percent diameter stenosis at nine months.

A second parallel study named the TAXUS PERSEUS Small Vessel study will compare the TAXUS Element Stent to a historic control (TAXUS V de novo bare-metal Express(R) Coronary Stent System). This study will include 224 patients from 35 U.S. sites with lesions from 2.25 up to 2.75 millimeters. The primary endpoint of the small vessel study is in-stent late loss at nine months, and its secondary endpoint is TLF at 12 months.

The TAXUS Element Stent is an
'/>"/>

SOURCE Boston Scientific Corporation
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4

Related medicine technology :

1. Wound Management Technologies, Inc. Announces Conference Plans in Boston and Additional Clinical Research on CellerateRx(R)
2. NIH Funds New Wellstone Research Center for Muscular Dystrophy at Boston Biomedical Research Institute
3. Boston Scientific Announces Schedule for European Society of Cardiology Congress 2008
4. Boston University and The Center for Human Genetics, Inc. Announce Change in Testing Services
5. Headache Specialists Convene in Boston For 50th Annual American Headache Society Meeting
6. Leading Immunologists Convene in Boston
7. Seven Presentations by Two Independent Research Groups Highlight Advantages of Pressure Cycling Technology (PCT) at Scientific Symposia in Philadelphia, Boston, and New York City
8. Multi-Center Patient Registry Supports Safety and Clinical Utility of Boston Scientifics SpyGlass(R) Direct Visualization System
9. SPIRIT III Results Reaffirm Strong Performance of Boston Scientific PROMUS(TM) and TAXUS(R) Express(R) Stents
10. Cequent Pharmaceuticals Johannes Fruehauf, MD, Ph.D., to be Featured Speaker at RNAi World Congress in Boston - May 2, 2008
11. Spirit II Results Support Strength of Boston Scientifics Two Drug-Eluting Stent Platforms
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/15/2009)... Champions Biotechnology, Inc . (OTC Bulletin Board: CSBR), ... preclinical platforms and tumor specific data to enhance ... financial results for the second fiscal quarter ended ... financial results are available in the Company,s Form ... for the second quarter of 2010 were $1,289,000 ...
(Date:12/15/2009)... newly formed industry, community and education initiative to advance ... is working to connect the orthopedics capital of the ... high-speed rail. ,, In a September report, ... World -- An overview, analysis and blueprint for ... statewide initiative to grow Indiana,s unique life sciences assets, ...
(Date:12/15/2009)... researchers with EDP Biotech Corporation (EDP) have captured ... a simple blood test to detect early-stage colon ... its pre-clinical trials for the ColoMarker(TM) assay, EDP ... and all aspects of its use. Via ... cancer in its earliest, most curable stages. ,, ...
Breaking Medicine Technology:Champions Biotechnology Reports Fiscal 2010 Second Quarter Financial Results 2Champions Biotechnology Reports Fiscal 2010 Second Quarter Financial Results 3Champions Biotechnology Reports Fiscal 2010 Second Quarter Financial Results 4Champions Biotechnology Reports Fiscal 2010 Second Quarter Financial Results 5OrthoWorx Urges Warsaw's Inclusion on High-Speed Rail Corridor Connecting Chicago and Cleveland 2OrthoWorx Urges Warsaw's Inclusion on High-Speed Rail Corridor Connecting Chicago and Cleveland 3Researchers Announce Medical Breakthrough with Simple, Inexpensive Blood Test for Colon Cancer 2Free Online Tools Benefitting Time Starved Cost Conscious Home Cooks 54709 1Free Online Tools Benefitting Time Starved Cost Conscious Home Cooks 54709 2Inc Magazine Names Enovate as One of the Fastest Growing Private Companies in the US 54707 1Inc Magazine Names Enovate as One of the Fastest Growing Private Companies in the US 54707 2Inc Magazine Names Enovate as One of the Fastest Growing Private Companies in the US 54707 3H1N1 Flu 28Swine Flu 29 Fears What People Can Do to Ease Them According to GLT Enviro 54703 1H1N1 Flu 28Swine Flu 29 Fears What People Can Do to Ease Them According to GLT Enviro 54703 2H1N1 Flu 28Swine Flu 29 Fears What People Can Do to Ease Them According to GLT Enviro 54703 3
... Marks Major Corporate Milestone and Advances ... Clinical ... today announced the approval of its second investigational new drug,(IND) application ... Company,s aromatase inhibitor (AI), in combination with,estrogen and progestin for the ...
... non-small, cell lung cancer patients receiving Tavocept in conjunction with standard ... ... of 6.5 months seen for patients with ... SAN ANTONIO, July 17 BioNumerik Pharmaceuticals, Inc.,("BioNumerik") today announced that ...
Other Medicine Technology:Meditrina Pharmaceuticals, Inc. Opens Investigational New Drug (IND) Application for Phase IIb Clinical Trial With MPI-676 in Endometriosis 2Meditrina Pharmaceuticals, Inc. Opens Investigational New Drug (IND) Application for Phase IIb Clinical Trial With MPI-676 in Endometriosis 3Meditrina Pharmaceuticals, Inc. Opens Investigational New Drug (IND) Application for Phase IIb Clinical Trial With MPI-676 in Endometriosis 4BioNumerik Pharmaceuticals Observes Evidence of a Survival Increase in Lung Cancer Patients Participating in Tavocept(TM) Clinical Trial 2BioNumerik Pharmaceuticals Observes Evidence of a Survival Increase in Lung Cancer Patients Participating in Tavocept(TM) Clinical Trial 3BioNumerik Pharmaceuticals Observes Evidence of a Survival Increase in Lung Cancer Patients Participating in Tavocept(TM) Clinical Trial 4
(Date:12/15/2009)... CITY, Dec. 15 The new compact LifeSpan ... ( www.LifeSpanFitness.com ), was highly praised by ... treadmills for 2010. The compact TR200 folding treadmill received ... Best Treadmill under $1000. ,, The compact LifeSpan ... in small workout spaces. "This category buster is a ...
(Date:12/15/2009)... new study links chronic obstructive pulmonary disease, or COPD, ... to activate the body,s immune system. , The ... growing awareness of the immune system,s role in COPD, ... 12 million Americans with wheezing, shortness of breath, chest ... if doctors are to find better ways to detect ...
(Date:12/15/2009)... combined with developmental changes increases risk in teens, study ... teenagers, being overweight or obese increases the risk of ... to be true for younger children, Australian researchers have ... children, aged 2 to 18, who were referred for ... researchers found that among those aged 12 and older ...
(Date:12/15/2009)... for injury when doctors decide benefits of imaging outweigh ... MRI scans can pose a serious risk to people ... Drug Administration researchers exposed pacemakers to a simulated MRI ... at the tip of the pacemaker lead, where it ... The exposure to MRI magnetic pulses caused certain pacemakers ...
(Date:12/15/2009)... NEW YORK, Dec. 15 ... research report is available in its ... Manufacturing Industry in the U.S. and ... ,, http://www.reportlinker.com/p0167482/In-Vitro-Diagnostic-Substance-Manufacturing-Industry-in-the-US-and-its-International-Trade-[Q4-2009-Edition].html ,, ... Manufacturing Industry report provides the latest ...
Breaking Medicine News(10 mins):Health News:Treadmill Reviews Rate Compact LifeSpan Treadmill Best Treadmill 2Health News:Immune cell activity linked to worsening COPD 2Health News:Immune cell activity linked to worsening COPD 3Health News:Puberty May Trigger Sleep Apnea in Overweight Kids 2Health News:Patients With Pacemakers Should Avoid MRI Scans 2Health News:Reportlinker Adds In-Vitro Diagnostic Substance Manufacturing Industry in the U.S. and its International Trade [Q4 2009 Edition] 2Health News:Reportlinker Adds In-Vitro Diagnostic Substance Manufacturing Industry in the U.S. and its International Trade [Q4 2009 Edition] 3Health News:Reportlinker Adds In-Vitro Diagnostic Substance Manufacturing Industry in the U.S. and its International Trade [Q4 2009 Edition] 4Health News:Reportlinker Adds In-Vitro Diagnostic Substance Manufacturing Industry in the U.S. and its International Trade [Q4 2009 Edition] 5Health News:Reportlinker Adds In-Vitro Diagnostic Substance Manufacturing Industry in the U.S. and its International Trade [Q4 2009 Edition] 6Health News:Reportlinker Adds In-Vitro Diagnostic Substance Manufacturing Industry in the U.S. and its International Trade [Q4 2009 Edition] 7Health News:Reportlinker Adds In-Vitro Diagnostic Substance Manufacturing Industry in the U.S. and its International Trade [Q4 2009 Edition] 8
... for action from ICANN, US-based domain ... ... an,online pharmacy verification service, and KnujOn.com, an Internet spam and,criminality watchdog, ... illicit sale of anabolic steroids., Steroid abuse is part of ...
... form of non-Hodgkin disease puts older men chiefly at ... News) -- The prevalence of mantle cell lymphoma, an ... patients are diagnosed with advanced stages of the disease, ... Texas M.D. Anderson Cancer Center. , Mantle cell ...
... July 18 In the last ten years over 360,children ... an average of 36,per year, according to a study by ... video from General Motors (NYSE: GM ) at:, http://media.medialink.com/WebNR.aspx?story=35362 ... many parents are,unaware of how dangerous a car can become ...
... Up For, WASHINGTON, July 18 Last week, ... that America,s,economic problems were "psychological" by saying Americans are ... "nation of whiners." While McCain,distanced himself from Gramm at ... top economic adviser. Now, John McCain is in Michigan, ...
... awareness campaign to raise awareness, of the importance ... ... Md., July 18 The COSHAR Foundation, a,nonprofit organization dedicated ... and disadvantaged populations, hosts,National Women,s Health Awareness Day on Saturday, ...
... ... in Texas, TYLER, Texas, July 18 Patients ... among the first,in the nation to have access to ... for a wide variety of cancers., (Logo: ...
Other Medicine News:Health News:Kids at Risk: Report Identifies 150 Websites Selling Anabolic Steroids 2Health News:Incidence of Mantle Cell Lymphoma on Rise 2Health News:DNC: McCain Watch: The Economy 2Health News:DNC: McCain Watch: The Economy 3Health News:The COSHAR Foundation Participates in Annual Women's Health Awareness Day 2Health News:The COSHAR Foundation Participates in Annual Women's Health Awareness Day 3Health News:Video: Trinity Mother Frances and Texas Oncology-Tyler Among the First in U.S. to Boast New Cancer-Fighting Technology 2Health News:Video: Trinity Mother Frances and Texas Oncology-Tyler Among the First in U.S. to Boast New Cancer-Fighting Technology 3Health News:Video: Trinity Mother Frances and Texas Oncology-Tyler Among the First in U.S. to Boast New Cancer-Fighting Technology 4Health News:Video: Trinity Mother Frances and Texas Oncology-Tyler Among the First in U.S. to Boast New Cancer-Fighting Technology 5
The Surgifresh mini has the same rugged construction as the Plume-inator. It is the ideal size for operating room, clinic and office settings. This unit includes a filter test button, hospital grade ...
A system for the removal and filtration of laser and surgical smoke....
The FreedomAire Surgical Helmet System is a lightweight, comfortable helmut system with superior air flow, and a removable motor module that lifts off for easy cleaning....
...
Medicine Products: